Acelyrin, Inc.
SLRN
$2.12
-$0.05-2.30%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 11.70M | 12.33M | 16.64M | 24.74M | 62.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 73.73M | 43.94M | 93.03M | 82.77M | 410.31M |
| Operating Income | -73.73M | -43.94M | -93.03M | -82.77M | -410.31M |
| Income Before Tax | -79.03M | -48.55M | -85.67M | -34.97M | -95.21M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -79.03M | -48.55M | -85.67M | -34.97M | -95.21M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -79.03M | -48.55M | -85.67M | -34.97M | -95.21M |
| EBIT | -73.73M | -43.94M | -93.03M | -82.77M | -410.31M |
| EBITDA | -73.58M | -43.83M | -92.91M | -82.72M | -410.27M |
| EPS Basic | -0.79 | -0.49 | -0.86 | -0.36 | -0.98 |
| Normalized Basic EPS | -0.25 | -0.24 | -0.54 | -0.45 | -2.60 |
| EPS Diluted | -0.79 | -0.49 | -0.86 | -0.36 | -0.98 |
| Normalized Diluted EPS | -0.25 | -0.24 | -0.54 | -0.45 | -2.60 |
| Average Basic Shares Outstanding | 100.28M | 99.84M | 99.16M | 97.91M | 97.58M |
| Average Diluted Shares Outstanding | 100.28M | 99.84M | 99.16M | 97.91M | 97.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |